{
    "clinical_study": {
        "@rank": "106098", 
        "acronym": "HNP", 
        "arm_group": [
            {
                "arm_group_label": "Stress management plus omega-3", 
                "arm_group_type": "Experimental", 
                "description": "Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant."
            }, 
            {
                "arm_group_label": "Stress management plus placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant."
            }, 
            {
                "arm_group_label": "Psychoeducation leaflet plus omega-3", 
                "arm_group_type": "Active Comparator", 
                "description": "Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant."
            }, 
            {
                "arm_group_label": "Psychoeducation leaflet plus placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant."
            }
        ], 
        "brief_summary": {
            "textblock": "The study is to explore the effectiveness of omega-3 fatty acids and mindfulness-based\n      stress management program to maintain healthy mental state in hospital nurses. The\n      participants will be junior nurses who work in inpatient wards and are not clinically\n      depressed. The participants will be randomly allocated to four intervention arms: 1)\n      Mindfulness-based stress management program plus omega-3 fatty acids pills ; 2)\n      Mindfulness-based stress management program plus placebo pills; 3) Psychoeducation leaflet\n      plus omega-3 fatty acids pills; and 4) Psychoeducation leaflet plus placebo pills. Thirty\n      participants will be allocated to each arm. These interventions will terminate until three\n      months from registration for each participant.\n\n      Information about depression and anxiety symptoms (primary outcome), insomnia, burnout,\n      presenteeism, quality of life, sick leave, consultation about mental state of herself, and\n      oxidative stress will be collected at 3 months, 6 months (primary time point) and 12 months\n      from registration for each participant."
        }, 
        "brief_title": "Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Depressive Disorder", 
            "Anxiety Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Depressive Disorder", 
                "Depression"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study is to explore the effectiveness of omega-3 fatty acids and mindfulness-based\n      stress management program to maintain healthy mental state in hospital nurses. The\n      participants will be junior nurses who work in inpatient wards at four general hospitals in\n      Tama region in Tokyo, and are not clinically depressed based on the score of the Hospital\n      Anxiety and Depression scale. The participants will be randomly allocated to four\n      intervention arms: 1) Mindfulness-based stress management program plus omega-3 fatty acids\n      pills; 2) Mindfulness-based stress management program plus placebo pills; 3) Psychoeducation\n      leaflet plus omega-3 fatty acids pills; and 4) Psychoeducation leaflet plus placebo pills.\n      Thirty participants will be allocated to each arm. These interventions will terminate until\n      3 months from registration for each participant. Stress management program will be conducted\n      by senior nurses in four individual sessions within these three months. Psychoeducation\n      leaflet will include information about screening of stress, sleep hygiene, relaxation, and a\n      list of consultants about mental health.\n\n      Information about depression and anxiety symptoms (primary outcome), insomnia, burnout,\n      presenteeism, quality of life, numbers of incident and accident at work, sick leave and\n      consultation about mental state of herself, concentration of fatty acids in serum and\n      oxidative stress will be collected at 3 months, 6 months (primary time point) and 12 months\n      from registration for each participant. The primary outcome will be assessed by blind raters\n      through telephone.\n\n      The outcomes will be compared between arms including stress management program and those\n      without, and between arms including omega-3 fatty acids and those without, by using mixed\n      model repeated measures model."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Work for inpatient wards in among four general hospitals in Tama region, Japan,\n             including: National Center of Neurology and Psychiatry Hospital, National Disaster\n             Medical Center, Tokyo Metropolitan Tama Medical Center, and Tama-Hokubu Medical\n             Center\n\n          -  Nurses without administration work\n\n          -  Give written consent in the participation of the study\n\n        Exclusion Criteria:\n\n          -  Have plans to take sick leave, leave for other reasons or retirement within 26 weeks\n             from the entry to the study\n\n          -  Take structured psychotherapy (e.g. cognitive behavioral therapy, interpersonal\n             therapy, and brief psychodynamic therapy) at the entry\n\n          -  See a physician regularly in order to treat any mood or anxiety disorders primarily\n             at the entry\n\n          -  Take antidepressants, mood stabilizers, anticonvulsants or antipsychotics at the\n             entry\n\n          -  Have taken nutrient supplement including omega-3 fatty acids for 4 or more weeks\n             within 52 weeks from the entry\n\n          -  Clinically depressed, based on the total score of 11 or more on the Hospital Anxiety\n             and Depression Scale - Depression Subscale and the total score of 15 or more on the\n             Primary Health Care Questionnaire\n\n          -  Consume 4 times or more of fish as the main course of meal per week\n\n          -  Take anticoagulant drugs at the entry or have previous history of stroke or\n             myocardial infarction\n\n          -  Judged ineligible by research coordinator due to any reason"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "59 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02151162", 
            "org_study_id": "IRG-NP-NCNP-25-8"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Stress management plus omega-3", 
                    "Stress management plus placebo"
                ], 
                "description": "Mindfulness-based stress management program will be conducted by senior nurses in four individual sessions within these three months. Senior nurses have taken a 7-hour workshop including lectures and role-playing sessions. The detailed manual and videos including lectures will be provided to the senior nurses.", 
                "intervention_name": "Mindfulness-based stress management program", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Stress management plus omega-3", 
                    "Psychoeducation leaflet plus omega-3"
                ], 
                "description": "Omega-3 fatty acids pills will include 1200 mg of eicosapentaenoic acid and 600 mg of docosahexaenoic acid per day.", 
                "intervention_name": "Omega-3 fatty acids pills", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Psychoeducation leaflet plus omega-3", 
                    "Psychoeducation leaflet plus placebo"
                ], 
                "description": "Psychoeducation leaflet will include information about screening of stress, sleep hygiene, relaxation, and a list of consultants about mental health.", 
                "intervention_name": "Psychoeducation leaflet", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Stress management plus placebo", 
                    "Psychoeducation leaflet plus placebo"
                ], 
                "description": "Placebo pills will include rapeseed oil, soybean oil, olive oil and fish oil.", 
                "intervention_name": "Placebo pills", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "contact": {
                "email": "narisawa@ncnp.go.jp", 
                "last_name": "Tomomi Narisawa, BA"
            }, 
            "facility": {
                "address": {
                    "city": "Kodaira", 
                    "country": "Japan", 
                    "state": "Tokyo", 
                    "zip": "187-8551"
                }, 
                "name": "National Center of Neurology and Psychiatry"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "4", 
        "official_title": "Mindfulness-Based Stress Management Program and Omega-3 Fatty Acids to Maintain Healthy Mental State in Hospital Nurses: Multi-Center Factorial-Design Randomized Controlled Trial Happy Nurse Project", 
        "other_outcome": {
            "description": "Information about any possible adverse events will be collected during the intervention period.", 
            "measure": "Adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "13 weeks"
        }, 
        "overall_contact": {
            "email": "noriow@ncnp.go.jp", 
            "last_name": "Norio Watanabe, MD, PhD", 
            "phone": "+81-42-341-2711", 
            "phone_ext": "7841"
        }, 
        "overall_official": {
            "affiliation": "National Center of Neurology and Psychiatry", 
            "last_name": "Norio Watanabe, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The total score of the HADS (HADS-T) ranges from 0 to 42, with higher scores indicating more symptoms. The HADS has two sub scores, each ranging from 0 to 21: HADS-D (depression) and HADS-A (anxiety). The total score will be used as the severity of depression and anxiety symptoms in the present study.", 
            "measure": "Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)", 
            "safety_issue": "No", 
            "time_frame": "26 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02151162"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "measure": "Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "Major depressive episode will be ascertained using the Primary Care Evaluation of Mental Disorders (PRIME-MD) algorithm with the depression module of the Patient Health Questionnaire (PHQ-9). The PHQ-9 was developed as a self-report version of the PRIME-MD which aims at Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) diagnosis of several common mental disorders.", 
                "measure": "Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "measure": "Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "Personal Health Questionnaire-9 is a 9-item structured questionnaire to measure depression severity.", 
                "measure": "Depression severity: Personal Health Questionnaire-9 (PHQ-9)", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Depression severity: Personal Health Questionnaire-9 (PHQ-9)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "measure": "Depression severity: Personal Health Questionnaire-9 (PHQ-9)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "The GAD-7 consists of 7 items, and the total score ranges from 0 to 21.", 
                "measure": "Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "measure": "Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "The ISI is now considered a standard measure of the global severity of insomnia and used in many studies. The total score between 8-14 indicates subthreshold insomnia; and 15-28, clinical insomnia. The total score of the ISI will be used as the severity of insomnia in the study.", 
                "measure": "Insomnia severity: Insomnia Severity Index (ISI)", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Insomnia severity: Insomnia Severity Index (ISI)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "measure": "Insomnia severity: Insomnia Severity Index (ISI)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "The BSI is a 44-item questionnaire for females about symptoms experienced in the previous month, which was designed to detect physical symptoms commonly related to depressed patients.", 
                "measure": "Somatic symptoms: The Bradford Somatic Inventory (BSI)", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Somatic symptoms: The Bradford Somatic Inventory (BSI)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "measure": "Somatic symptoms: The Bradford Somatic Inventory (BSI)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "The HPQ is a self-report instrument designed to estimate the workplace costs of health problems in terms of self-reported reduced job performance (presenteeism).", 
                "measure": "Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "measure": "Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "The MBI is a self-report measure with 22 items and is calculated into three sub-domains such as emotional exhaustion, depersonalization and personal accomplishment.", 
                "measure": "Burnout: Maslach Burnout Inventory (MBI)", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Burnout: Maslach Burnout Inventory (MBI)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "measure": "Burnout: Maslach Burnout Inventory (MBI)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.", 
                "measure": "Quality of Life: EuroQol (EQ-5D)", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "description": "EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.", 
                "measure": "Quality of Life: EuroQol (EQ-5D)", 
                "safety_issue": "No", 
                "time_frame": "13 weeks"
            }, 
            {
                "description": "EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.", 
                "measure": "Quality of Life: EuroQol (EQ-5D)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }
        ], 
        "source": "National Center of Neurology and Psychiatry, Japan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Center of Neurology and Psychiatry, Japan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}